Presentation TCT 2017 What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants Presenter: Freek W.A. Verheugt November 01, 2017 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2017 CAD Pharma Up Next Presentation TCT 2017 Guidelines and Expert Consensus on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI: How Strong Is the Evidence? Presenter: Jean-François Tanguay November 01, 2017 More slides + Presentation TCT 2017 Should the Type of Stent Influence DAPT Decisions in Patients Receiving OAC? Insights From WOEST, LEADERS Free, and More Presenter: Didier Carrié November 01, 2017 Presentation TCT 2017 Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding Presenter: Michelle O'Donoghue November 01, 2017 We Recommend
Presentation TCT 2017 Guidelines and Expert Consensus on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI: How Strong Is the Evidence? Presenter: Jean-François Tanguay November 01, 2017
Presentation TCT 2017 Should the Type of Stent Influence DAPT Decisions in Patients Receiving OAC? Insights From WOEST, LEADERS Free, and More Presenter: Didier Carrié November 01, 2017
Presentation TCT 2017 Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding Presenter: Michelle O'Donoghue November 01, 2017